Azitra (AZTR) Change in Taxes (2022 - 2026)
Azitra (AZTR) reported Change in Taxes of -$6256.0 for Q1 2026, up 45.94% on a YoY basis from -$4286.7 in Q1 2025, and up 47.42% quarter-over-quarter from -$11898.0 in Q4 2025.
Azitra (AZTR) Change in Taxes (2022 - 2026) Analysis & Trends
Azitra has reported Change in Taxes for 5 years, with the latest figure at -$6256.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Taxes rose 45.94% year-over-year to -$6256.0; the trailing twelve-month figure through Mar 2026 stood at $10632.0 (up 128.44% YoY), and the FY2025 full-year result was $5316.0, up 128.88% from the prior year.
- Change in Taxes for Q1 2026 stood at -$6256.0, up from -$11898.0 in the prior quarter.
- The five-year high for Change in Taxes was $152516.0 in Q4 2022, with the low at -$276826.0 in Q3 2022.
- Historically, Change in Taxes has averaged -$13685.8 across 5 years, with a median of -$6886.0 in 2023.
- The largest YoY upside for Change in Taxes was 139.63% in 2025 against a maximum downside of 256.4% in 2025.
- Azitra's Change in Taxes stood at $152516.0 in 2022, then sank by 104.51% to -$6886.0 in 2023, then plunged by 68.05% to -$11572.0 in 2024, then retreated by 2.82% to -$11898.0 in 2025, then surged by 47.42% to -$6256.0 in 2026.
- The last three Change in Taxes figures came in at -$6256.0 (Q1 2026), -$11898.0 (Q4 2025), and $5642.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | -6,256.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,256.00 |
| Mar 31, 2026 | -6,256.00 |
| Dec 31, 2025 | -11,898.00 |
| Dec 31, 2025 | -11,898.00 |
| Sep 30, 2025 | 5,642.00 |
| Sep 30, 2025 | 5,642.00 |
| Jun 30, 2025 | 23,144.00 |
| Jun 30, 2025 | 23,144.00 |
| Mar 31, 2025 | -11,572.00 |
| Mar 31, 2025 | -11,572.00 |
| Dec 31, 2024 | -11,572.00 |
| Dec 31, 2024 | -11,572.00 |
| Sep 30, 2024 | -14,235.00 |
| Sep 30, 2024 | -14,235.00 |
| Mar 31, 2024 | 7,399.00 |
| Mar 31, 2024 | 7,399.00 |
| Dec 31, 2023 | -6,886.00 |
| Dec 31, 2023 | -6,886.00 |
| Dec 31, 2022 | 152,516.00 |
| Dec 31, 2022 | 152,516.00 |